Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4K Buy
+227
New +$1.42K ﹤0.01% 4902
2023
Q1
Sell
-7
Closed -$140 5124
2022
Q4
$140 Sell
7
-26
-79% -$603 ﹤0.01% 5195
2022
Q3
$2K Sell
33
-8
-20% -$530 ﹤0.01% 4624
2022
Q2
$2K Sell
41
-125
-75% -$6.98K ﹤0.01% 4875
2022
Q1
$13K Buy
+166
New +$10K ﹤0.01% 4545

Other funds holding CLNN

Barclays's CLNN Position: Q2 2026 in Review

Barclays opened a new position in Clene (CLNN) in Q2 2026: 227 shares worth $1.4K. The stake represents ﹤0.01% of the portfolio and ranks #4902 among its holdings. This is a return to the name: Barclays previously reported a position in CLNN as recently as Q4 2022.

Barclays first reported a position in CLNN in Q1 2022 and has held it in 5 quarters since. The position peaked at $13K in Q1 2022. 33 funds tracked by Wall St. Rank hold CLNN as of Q2 2026.

  • Barclays held 227 shares of Clene worth $1.4K as of Q2 2026.
  • Clene was a new Barclays position in Q2 2026.
  • Clene made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4902 holding.
  • Barclays first reported a position in Clene in Q1 2022 and has held it in 5 quarters since.
  • Barclays's Clene position peaked at $13K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Clene as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.